Literature DB >> 1510457

Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I.

M Fukasawa1, Y Sumita, E T Harabe, T Tanio, H Nouda, T Kohzuki, T Okuda, H Matsumura, M Sunagawa.   

Abstract

The stability of meropenem in the presence of renal dehydropeptidase I (DHP-I) varied extremely with the animal source of the enzyme. Meropenem, compared with imipenem, was rather easily hydrolyzed by DHP-Is from mice, rabbits, and monkeys, while it showed a higher resistance to guinea pig and beagle dog DHP-Is. In addition, meropenem was four times more resistant than imipenem to human DHP-I. The 1 beta-methyl substituent on carbapenems, i.e., meropenem and 1 beta-methyl imipenem, made them considerably more resistant to mouse and swine DHP-Is than the 1-unsubstituted derivatives are.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510457      PMCID: PMC191626          DOI: 10.1128/AAC.36.7.1577

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Purification and properties of human kidney dipeptidases.

Authors:  M Sugiura; Y Ito; K Hirano; S Sawaki
Journal:  Biochim Biophys Acta       Date:  1978-02-10

3.  Structures of olivanic acid derivatives MM 22380, MM 22381, MM 22382 and MM 22383; four new antibiotics isolated from Streptomyces olivaceus.

Authors:  A G Brown; D F Corbett; A J Eglington; T T Howarth
Journal:  J Antibiot (Tokyo)       Date:  1979-09       Impact factor: 2.649

4.  Carpetimycins A and B, new beta-lactam antibiotics.

Authors:  M Nakayama; A Iwasaki; S Kimura; T Mizoguchi; S Tanabe; A Murakami; I Watanabe; M Okuchi; H Itoh; Y Saino; F Kobayashi; T Mori
Journal:  J Antibiot (Tokyo)       Date:  1980-11       Impact factor: 2.649

5.  The purification and properties of a particulate renal dipeptidase.

Authors:  B J Campbell; Y C Lin; R V Davis; E Ballew
Journal:  Biochim Biophys Acta       Date:  1966-05-05

6.  Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.

Authors:  J S Bakken; C C Sanders; R B Clark; M Hori
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

7.  Characterization of dehydropeptidase I in the rat lung.

Authors:  T Hirota; Y Nishikawa; M Tanaka; T Igarashi; H Kitagawa
Journal:  Eur J Biochem       Date:  1986-11-03

8.  Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

Authors:  J S Kahan; F M Kahan; R Goegelman; S A Currie; M Jackson; E O Stapley; T W Miller; A K Miller; D Hendlin; S Mochales; S Hernandez; H B Woodruff; J Birnbaum
Journal:  J Antibiot (Tokyo)       Date:  1979-01       Impact factor: 2.649

9.  Properties of novel beta-lactamase produced by Bacteroides fragilis.

Authors:  A Yotsuji; S Minami; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

10.  Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.

Authors:  H Kropp; J G Sundelof; R Hajdu; F M Kahan
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

View more
  38 in total

Review 1.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo.

Authors:  Kathleen England; Helena I M Boshoff; Kriti Arora; Danielle Weiner; Emmanuel Dayao; Daniel Schimel; Laura E Via; Clifton E Barry
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

3.  Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.

Authors:  Emma Padilla; Diana Alonso; Antonio Doménech-Sánchez; Cristina Gomez; José Luis Pérez; Sebastián Albertí; Nuria Borrell
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.

Authors:  H K Jones; H C Kelly; M Hutchison; R A Yates; F Ross; C Lomax; S Freestone; D Webb
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.441

Review 5.  Meropenem: a review of its use in patients in intensive care.

Authors:  M Hurst; H M Lamb
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

6.  Kinetics of imipenem distribution into the peritoneal fluid of patients with severe peritonitis studied by microdialysis.

Authors:  Claire Dahyot-Fizelier; Sandrine Lefeuvre; Leila Laksiri; Sandrine Marchand; Ronald J Sawchuk; William Couet; Olivier Mimoz
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

7.  Crystal structure of the carbapenem intrinsic resistance protein CarG.

Authors:  E M Tichy; B F Luisi; G P C Salmond
Journal:  J Mol Biol       Date:  2014-02-28       Impact factor: 5.469

8.  Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animals.

Authors:  Takahiro Shibayama; Yoko Matsushita; Kenji Kawai; Takashi Hirota; Toshihiko Ikeda; Shogo Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

9.  Experimental study of meropenem in the therapy of cephalosporin-susceptible and -resistant pneumococcal meningitis.

Authors:  E Force; F Taberner; C Cabellos; S Ribes; A Domenech; F Tubau; P F Viladrich; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-04-02       Impact factor: 3.267

Review 10.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.